Search

Author/Creator Krueger, J. G.

1. A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis. (14th September 2020)

Authors:
Berstein, G.; Zhang, Y.; Berger, Z.; Kieras, E.; Li, G.; Samuel, A.; Yeoh, T.; Dowty, H.; Beaumont, K.; Wigger‐Alberti, W.; von Mackensen, Y.; Kroencke, U.; Hamscho, R.; Garcet, S.; Krueger, J. G.; Banfield, C.; Oemar, B.
Journal:
Clinical and experimental dermatology
Issue:
Volume 46:Number 1(2021)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis. (1st January 2021)

Authors:
Berstein, G.; Zhang, Y.; Berger, Z.; Kieras, E.; Li, G.; Samuel, A.; Yeoh, T.; Dowty, H.; Beaumont, K.; Wigger‐Alberti, W.; von Mackensen, Y.; Kroencke, U.; Hamscho, R.; Garcet, S.; Krueger, J. G.; Banfield, C.; Oemar, B.
Journal:
Clinical and experimental dermatology
Issue:
Volume 46:Number 1(2021)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin‐homing and systemic T‐cell populations. Issue 3 (22nd December 2017)

Authors:
Czarnowicki, T.; He, H. Y.; Wen, H.‐C.; Hashim, P. W.; Nia, J. K.; Malik, K.; Estrada, Y.; Kimmel, G. W.; Taliercio, M.; Krueger, J. G.; Guttman‐Yassky, E.
Journal:
Allergy
Issue:
Volume 73:Issue 3(2018)
Page Start:
713
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab. (1st March 2021)

Authors:
Frew, J. W.; Jiang, C. S.; Singh, N.; Grand, D.; Navrazhina, K.; Vaughan, R.; Krueger, J. G.
Journal:
Clinical and experimental dermatology
Issue:
Volume 46:Number 2(2021)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab. (22nd October 2020)

Authors:
Frew, J. W.; Jiang, C. S.; Singh, N.; Grand, D.; Navrazhina, K.; Vaughan, R.; Krueger, J. G.
Journal:
Clinical and experimental dermatology
Issue:
Volume 46:Number 2(2021)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function. (12th September 2018)

Authors:
Seidel, J. A.; Vukmanovic‐Stejic, M.; Muller‐Durovic, B.; Patel, N.; Fuentes‐Duculan, J.; Henson, S. M.; Krueger, J. G.; Rustin, M. H. A.; Nestle, F. O.; Lacy, K. E.; Akbar, A. N.
Journal:
Clinical and experimental immunology
Issue:
Volume 194:Number 1(2018:Oct.)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗